Quantbot Technologies’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-21,334
Closed -$2.12M 1758
2019
Q3
$2.12M Buy
21,334
+20,334
+2,033% +$1.93M 0.21% 134
2019
Q2
$92K Sell
1,000
-82,216
-99% -$7.81M 0.01% 779
2019
Q1
$7.85M Buy
83,216
+12,178
+17% +$1.07M 0.75% 13
2018
Q4
$4.55M Buy
71,038
+33,339
+88% +$2.46M 0.45% 49
2018
Q3
$3.37M Sell
37,699
-36,137
-49% -$3.19M 0.24% 124
2018
Q2
$5.86M Buy
+73,836
New +$6.13M 0.4% 49
2018
Q1
Sell
-17,000
Closed -$1.77M 1707
2017
Q4
$1.77M Buy
+17,000
New +$1.92M 0.16% 181
2017
Q3
Sell
-15,011
Closed -$1.95M 1590
2017
Q2
$1.95M Buy
+15,011
New +$1.84M 0.18% 147
2017
Q1
Sell
-20,535
Closed -$2.38M 1571
2016
Q4
$2.38M Buy
+20,535
New +$2.29M 0.26% 87
2016
Q3
Sell
-9,666
Closed -$953K 1502
2016
Q2
$953K Sell
9,666
-1,226
-11% -$127K 0.1% 239
2016
Q1
$1.09M Buy
+10,892
New +$1.12M 0.17% 164
2015
Q4
Sell
-5,868
Closed -$634K 1632
2015
Q3
$634K Buy
+5,868
New +$728K 0.11% 214
2015
Q2
Sell
-25,309
Closed -$2.92M 1566
2015
Q1
$2.92M Buy
25,309
+22,040
+674% +$2.63M 0.72% 19
2014
Q4
$365K Buy
+3,269
New +$345K 0.12% 264
2014
Q3
Sell
-3,929
Closed -$337K 1648
2014
Q2
$337K Buy
+3,929
New +$299K 0.05% 426

Other funds holding CELG

Quantbot Technologies's CELG Position: Q4 2019 in Review

Quantbot Technologies sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 21,334 shares — an estimated $2.12M sold.

Quantbot Technologies first reported a position in CELG in Q2 2014 and held it in 15 quarters. The position peaked at $7.85M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Quantbot Technologies reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Quantbot Technologies sold 21,334 Celgene Corp shares in Q4 2019, an estimated $2.12M.
  • Quantbot Technologies first reported a position in Celgene Corp in Q2 2014 and held it in 15 quarters.
  • Quantbot Technologies's Celgene Corp position peaked at $7.85M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Quantbot Technologies's 13F filing for Q4 2019, filed 10 Feb 2020.